Multi-fiber distributed thermal profiling of minimally invasive thermal ablation with scattering-level multiplexing in MgO-doped fibers

[EN] We propose a setup for multiplexed distributed optical fiber sensors capable of resolving temperature distribution in thermo-therapies, with a spatial resolution of 2.5 mm over multiple fibers interrogated simultaneously. The setup is based on optical backscatter reflectometry (OBR) applied to optical fibers having backscattered power significantly larger than standard fibers (36.5 dB), obtained through MgO doping. The setup is based on a scattering-level multiplexing, which allows interrogating all the sensing fibers simultaneously, thanks to the fact that the backscattered power can be unambiguously associated to each fiber. The setup has been validated for the planar measurement of temperature profiles in ex vivo radiofrequency ablation, obtaining the measurement of temperature over a surface of 96 total points (4 fibers, 8 sensing points per cu). The spatial resolution obtained for the planar measurement allows extending distributed sensing to surface, or even three-dimensional, geometries performing temperature sensing in the tissue with millimeter resolution in multiple dimensions.The research has been supported by ORAU program at Nazarbayev University (grants LIFESTART 2017-2019 and FOSTHER2018-2020), by ANR project Nice-DREAM (grant ANR-14-CE07-0016-03), and by project DIMENSION TEC2017 88029-R funded by the Spanish Ministry of Economy and Competitiveness. This work was partly supported by the SIRASI project - Sistema Robotico a supporto della Riabilitazione di Arto Superiore e Inferiore (Bando INTESE - CUP: F86D15000050002).Beisenova, A.; Issatayeva, A.; Sovetov, S.; Korganbayev, S.; Jelbuldina, M.; Ashikbayeva, Z.; Blanc, W.... (2019). Multi-fiber distributed thermal profiling of minimally invasive thermal ablation with scattering-level multiplexing in MgO-doped fibers. Biomedical Optics Express. 10(3):1282-1296. https://doi.org/10.1364/BOE.10.001282S12821296103Goldberg, S. N., Gazelle, G. S., Compton, C. C., Mueller, P. R., & Tanabe, K. K. (2000). Treatment of intrahepatic malignancy with radiofrequency ablation. Cancer, 88(11), 2452-2463. doi:10.1002/1097-0142(20000601)88:113.0.co;2-3Padma, S., Martinie, J. B., & Iannitti, D. A. (2009). Liver tumor ablation: Percutaneous and open approaches. Journal of Surgical Oncology, 100(8), 619-634. doi:10.1002/jso.21364Sapareto, S. A., & Dewey, W. C. (1984). Thermal dose determination in cancer therapy. International Journal of Radiation Oncology*Biology*Physics, 10(6), 787-800. doi:10.1016/0360-3016(84)90379-1Shaw, A., ter Haar, G., Haller, J., & Wilkens, V. (2015). Towards a dosimetric framework for therapeutic ultrasound. International Journal of Hyperthermia, 31(2), 182-192. doi:10.3109/02656736.2014.997311Lubner, M. G., Brace, C. L., Hinshaw, J. L., & Lee, F. T. (2010). Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and Devices. Journal of Vascular and Interventional Radiology, 21(8), S192-S203. doi:10.1016/j.jvir.2010.04.007Kennedy, J. E. (2005). High-intensity focused ultrasound in the treatment of solid tumours. Nature Reviews Cancer, 5(4), 321-327. doi:10.1038/nrc1591Yang, X. (2017). Science to Practice: Enhancing Photothermal Ablation of Colorectal Liver Metastases with Targeted Hybrid Nanoparticles. Radiology, 285(3), 699-701. doi:10.1148/radiol.2017170993Tosi, D., Schena, E., Molardi, C., & Korganbayev, S. (2018). Fiber optic sensors for sub-centimeter spatially resolved measurements: Review and biomedical applications. Optical Fiber Technology, 43, 6-19. doi:10.1016/j.yofte.2018.03.007Manns, F., Milne, P. J., Gonzalez-Cirre, X., Denham, D. B., Parel, J.-M., & Robinson, D. S. (1998). In Situ temperature measurements with thermocouple probes during laser interstitial thermotherapy (LITT): Quantification and correction of a measurement artifact. Lasers in Surgery and Medicine, 23(2), 94-103. doi:10.1002/(sici)1096-9101(1998)23:23.0.co;2-qSaccomandi, P., Schena, E., & Silvestri, S. (2013). Techniques for temperature monitoring during laser-induced thermotherapy: An overview. International Journal of Hyperthermia, 29(7), 609-619. doi:10.3109/02656736.2013.832411Froggatt, M. (1996). Distributed measurement of the complex modulation of a photoinduced Bragg grating in an optical fiber. Applied Optics, 35(25), 5162. doi:10.1364/ao.35.005162Macchi, E. G., Tosi, D., Braschi, G., Gallati, M., Cigada, A., Busca, G., & Lewis, E. (2014). Optical fiber sensors-based temperature distribution measurement inex vivoradiofrequency ablation with submillimeter resolution. Journal of Biomedical Optics, 19(11), 117004. doi:10.1117/1.jbo.19.11.117004Palumbo, G., Iadicicco, A., Tosi, D., Verze, P., Carlomagno, N., Tammaro, V., … Campopiano, S. (2016). Temperature profile of ex-vivo organs during radio frequency thermal ablation by fiber Bragg gratings. Journal of Biomedical Optics, 21(11), 117003. doi:10.1117/1.jbo.21.11.117003Parent, F., Loranger, S., Mandal, K. K., Iezzi, V. L., Lapointe, J., Boisvert, J.-S., … Kashyap, R. (2017). Enhancement of accuracy in shape sensing of surgical needles using optical frequency domain reflectometry in optical fibers. Biomedical Optics Express, 8(4), 2210. doi:10.1364/boe.8.002210MacChesney, J. B., O’Connor, P. B., & Presby, H. M. (1974). A new technique for the preparation of low-loss and graded-index optical fibers. Proceedings of the IEEE, 62(9), 1280-1281. doi:10.1109/proc.1974.9608Blanc, W., Mauroy, V., Nguyen, L., Shivakiran Bhaktha, B. N., Sebbah, P., Pal, B. P., & Dussardier, B. (2011). Fabrication of Rare Earth-Doped Transparent Glass Ceramic Optical Fibers by Modified Chemical Vapor Deposition. Journal of the American Ceramic Society, 94(8), 2315-2318. doi:10.1111/j.1551-2916.2011.04672.xBlanc, W., Guillermier, C., & Dussardier, B. (2012). Composition of nanoparticles in optical fibers by Secondary Ion Mass Spectrometry. Optical Materials Express, 2(11), 1504. doi:10.1364/ome.2.001504Todd, N., Diakite, M., Payne, A., & Parker, D. L. (2013). In vivo evaluation of multi-echo hybrid PRF/T1 approach for temperature monitoring during breast MR-guided focused ultrasound surgery treatments. Magnetic Resonance in Medicine, 72(3), 793-799. doi:10.1002/mrm.2497

Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction

BACKGROUND: There are no randomised and properly blinded trials directly comparing one PDE-5 inhibitor with another in a normal home setting. Valid indirect comparisons with a common comparator must examine equivalent doses, similar duration, similar populations, with the same outcomes reported in the same way. METHODS: Published randomised, double-blind trials of oral PDE-5 inhibitors for erectile dysfunction were sought from reference lists in previous reviews and electronic searching. Analyses of efficacy and harm were carried out for each treatment, and results compared where there was a common comparator and consistency of outcome reporting, using equivalent doses. RESULTS: Analysis was limited by differential reporting of outcomes. Sildenafil trials were clinically and geographically more diverse. Tadalafil and vardenafil trials tended to use enriched enrolment. Using all trials, the three interventions were similar for consistently reported efficacy outcomes. Rates of successful intercourse for sildenafil, tadalafil and vardenafil were 65%, 62%, and 59%, with placebo rates of 23–28%. The rates of improved erections were 76%, 75% and 71%, respectively, with placebo rates of 22–24%, and NNTs of 1.9 or 2.0. Reporting of withdrawals was less consistent, but all-cause withdrawals for sildenafil, tadalafil and vardenafil were 8% 13% and 20%. All three drugs were well tolerated, with headache being the most commonly reported event at 13–17%. There were few serious adverse events. CONCLUSION: There were differences between trials in outcomes reported, limiting comparisons, and the most useful outcomes were not reported. For common outcomes there was similar efficacy between PDE-5 inhibitors

Characterization of 9-Nitrocamptothecin Liposomes: Anticancer Properties and Mechanisms on Hepatocellular Carcinoma In Vitro and In Vivo

BACKGROUND: Hepatocellular carcinoma (HCC) is the third most common cause of cancer related mortality worldwide. 9-Nitrocamptothecin (9NC) is a potent topoisomerase-I inhibitor with strong anticancer effect. To increase the solubility and stability, we synthesized a novel 9NC loaded liposomes (9NC-LP) via incorporating 9NC into liposomes. In the present study, we determined the effects of 9NC and 9NC-LP on in vitro and in vivo, and the underlying mechanisms. METHODOLOGY/PRINCIPAL FINDINGS: We first analyzed the characteristics of 9NC-LP. Then we compared the effects of 9NC and 9NC-LP on the proliferation and apoptosis of HepG2, Bel-7402, Hep3B and L02 cells in vitro. We also investigated their anticancer properties in nude mice bearing HCC xenograft in vivo. 9NC-LP has a uniform size (around 190 nm) and zeta potential (∼-11 mV), and exhibited a steady sustained-release pattern profile in vitro. Both 9NC and 9NC-LP could cause cell cycle arrest and apoptosis in a dose-dependent and p53-dependent manner. However, this effect was not ubiquitous in all cell lines. Exposure to 9NC-LP led to increased expression of p53, p21, p27, Bax, caspase-3, caspase-8, caspase-9 and apoptosis-inducing factor, mitochondrion-associated 1 and decreased expression of Bcl-2, cyclin E, cyclin A, Cdk2 and cyclin D1. Furthermore, 9NC-LP exhibited a more potent antiproliferative effect and less side effects in vivo. Western blot analysis of the xenograft tumors in nude mice showed similar changes in protein expression in vivo. CONCLUSIONS/SIGNIFICANCE: In conclusion, 9NC and 9NC-LP can inhibit HCC growth via cell cycle arrest and induction of apoptosis. 9NC-LP has a more potent anti-tumor effect and fewer side effects in vivo, which means it is a promising reagent for cancer therapy via intravenous administration

Changes in Culture Expanded Human Amniotic Epithelial Cells: Implications for Potential Therapeutic Applications

Human amniotic epithelial cells (hAEC) isolated from term placenta have stem cell-like properties, differentiate into tissue specific cells and reduce lung and liver inflammation and fibrosis following transplantation into disease models established in mice. These features together with their low immunogenicity and immunosuppressive properties make hAEC an attractive source of cells for potential therapeutic applications. However, generation of large cell numbers required for therapies through serial expansion in xenobiotic-free media may be a limiting factor. We investigated if hAEC could be expanded in xenobiotic-free media and if expansion altered their differentiation capacity, immunophenotype, immunosuppressive properties and production of immunomodulatory factors. Serial expansion in xenobiotic-free media was limited with cumulative cell numbers and population doubling times significantly lower than controls maintained in fetal calf serum. The epithelial morphology of primary hAEC changed into mesenchymal-stromal like cells by passage 4–5 (P4–P5) with down regulation of epithelial markers CK7, CD49f, EpCAM and E-cadherin and elevation of mesenchymal-stromal markers CD44, CD105, CD146 and vimentin. The P5 hAEC expanded in xenobiotic-free medium differentiated into osteocyte and alveolar epithelium-like cells, but not chondrocyte, hepatocyte, α- and β-pancreatic-like cells. Expression of HLA Class IA, Class II and co-stimulatory molecules CD80, CD86 and CD40 remained unaltered. The P5 hAEC suppressed mitogen stimulated T cell proliferation, but were less suppressive compared with primary hAEC at higher splenocyte ratios. Primary and P5 hAEC did not secrete the immunosuppressive factors IL-10 and HGF, whereas TGF-β1 and HLA-G were reduced and IL-6 elevated in P5 hAEC. These findings suggest that primary and expanded hAEC may be suitable for different cellular therapeutic applications

A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates

Chikungunya virus (CHIKV) is an emerging mosquito-borne alphavirus indigenous to tropical Africa and Asia. Acute illness is characterized by fever, arthralgias, conjunctivitis, rash, and sometimes arthritis. Relatively little is known about the antigenic targets for immunity, and no licensed vaccines or therapeutics are currently available for the pathogen. While the Aedes aegypti mosquito is its primary vector, recent evidence suggests that other carriers can transmit CHIKV thus raising concerns about its spread outside of natural endemic areas to new countries including the U.S. and Europe. Considering the potential for pandemic spread, understanding the development of immunity is paramount to the development of effective counter measures against CHIKV. In this study, we isolated a new CHIKV virus from an acutely infected human patient and developed a defined viral challenge stock in mice that allowed us to study viral pathogenesis and develop a viral neutralization assay. We then constructed a synthetic DNA vaccine delivered by in vivo electroporation (EP) that expresses a component of the CHIKV envelope glycoprotein and used this model to evaluate its efficacy. Vaccination induced robust antigen-specific cellular and humoral immune responses, which individually were capable of providing protection against CHIKV challenge in mice. Furthermore, vaccine studies in rhesus macaques demonstrated induction of nAb responses, which mimicked those induced in convalescent human patient sera. These data suggest a protective role for nAb against CHIKV disease and support further study of envelope-based CHIKV DNA vaccines

Counseling patients about sexual health when considering post-prostatectomy radiation treatment

Prostate cancer is the second most frequently diagnosed cancer in men in the United States. Many men with clinically localized prostate cancer survive for 15 years or more. Although early detection and successful definitive treatments are increasingly common, a debate regarding how aggressively to treat prostate cancer is ongoing because of the effect of aggressive treatment on the quality of life, including sexual functioning. We examined current research on the effect of post-prostatectomy radiation treatment on sexual functioning, and suggest a way in which patient desired outcomes might be taken into consideration while making decisions with regard to the timing of radiation therapy after prostatectomy